CORRESPONDENCE
In an article published in the June 2014 issue of Nature Reviews Endocrinology (The pathophysiology of hypertension in patients with obesity. Nat. Rev. Endocrinol. 10, 364-376; 2014), 1 Vincent G. DeMarco and colleagues reviewed the potential mecha nisms that can link obesity to hyper tension, including dietary factors, metabolic, endo thelial and vascular dysfunc tion, neuro endocrine imbalances, sodium reten tion, glomerular hyperfiltration, protein uria, mal adaptive immune and inflammatory res ponses, uric acid and altered incretin or dipeptidyl peptidase 4 activity, as well as the role of the gut m icrobiota in mo dulating these mechanisms. 1 However, we would like to add another potentially important mechanism that could contribute to hypertension in patients with obesity-hypothalamic inflamma tion. The hypothalamus is a key region of the brain that regulates the activity of the sympathetic nervous system (SNS). Studies published in the past 6 years suggest that obesityassociated hypertension depends on the activation of proinflammatory path ways such as those involving IκB kinase (IKK)β and nuclear factor κB (NFκB) in proopiomelanocortin (POMC) neurons of the arcuate nucleus in the hypothalamus.
2,3
Purkayastha et al. 2 showed that virus mediated gene delivery of constitutively active IKKβ to the mediobasal hypo thalamus in mice caused hypertension even when the mice were fed normal chow. Mice with obesity induced by ingesting a highfat diet were hypertensive, but inactivation of NFκB through mediobasal hypothalamic injection of a dominant negative form of Hypertension in obesity: the role of hypothalamic inflammation
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IκBα in these mice led to a notable drop in blood pressure. 2 Humphreys et al. 4 ,5 specu lated that both αmelanocyte stimulating hormones (MSHs) and γMSHs, which are derived from POMC, regulate SNS outflow. They further suggested that if IKKβ and NFκB activation leads to increased pro cessing of POMC into these peptides, it could cause hypertension via an increase in sympathetic activity, as obese mice defi cient in melanocortin 4 receptor, in which MSH peptides cannot bind to the receptor, have normal blood pressure. These results suggest that the cause of the hypertension in animals with dietinduced obesity can be separated from the path ways mediat ing the obesity. Mechanistically, these studies indicate that hypothalamic inflam mation is implicated in the pathogenes is of hypertension.
Also interestingly, Zhang et al. 3 reported that overnutrition atypically activated hypo thalamic IKKβ and NFκB, which might be partly attributable to increased endo plasmic reticulum stress in the hypothala mus. Although the mechanisms leading to hypothalamic IKKβ and NFκB activation are yet to be elucidated, Purkayastha et al. 2 showed that TNF stimulated the IKKβ and NFκB pathways in POMC neurons and ele vated blood pressure via a central mecha nism involving SNS activation. Similarly, Jang et al. 6 demonstrated that leptin could also stimulate IKKβ and NFκB signalling in POMC neurons, which suggests that these molecules are the factors that could explain obesityassociated hypertension.
Therefore, hypertension in patients with obesity could be related to hypothalamic inflammation via IKKβ and NFκB acti vation that can be induced by excess levels of TNF and leptin in patients with obes ity. Further studies are necessary to evaluate the effect of the various cytokines that are increased in patients with obesity when IKKβ and NFκB are activated in the hypo thalamus and to elucidate if target ing the IKKβ and NFκB pathways in the hypo thalamus (including POMC neurons) is bene ficial in the treatment of obesity associated hypertension.
